How Cumberland Pharma’s Ifetroban Could Transform Duchenne Cardiomyopathy Treatment
How Cumberland Pharmaceuticals’ ifetroban could change Duchenne muscular dystrophy treatment, with FDA rolling‑review and rare‑disease designations.
3 minutes to read